BioLineRx Ltd. (ADR)
General ticker "BLRX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $260.2M (TTM average)
BioLineRx Ltd. (ADR) does not follow the US Stock Market performance with the rate: -2.4%.
Estimated limits based on current volatility of 3.2%: low 2.17$, high 2.31$
Factors to consider:
- Total employees count: 52 as of 2011
- Current price 55.4% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [6.37$, 21.44$]
- 2025-12-31 to 2026-12-31 estimated range: [5.09$, 17.07$]
Financial Metrics affecting the BLRX estimates:
- Positive: with PPE of 2.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -6.43 <= 0.01
- Negative: Industry earnings per price (median), % of -15.81 <= 0
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: negative Net income
- Positive: 19.40 < Shareholder equity ratio, % of 34.60 <= 42.68
- Positive: Interest expense per share per price, % of 1.34 <= 3.28
Short-term BLRX quotes
Long-term BLRX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $4.80MM | $28.94MM | $1.19MM |
| Operating Expenses | $54.49MM | $49.35MM | $11.56MM |
| Operating Income | $-49.69MM | $-20.41MM | $-10.37MM |
| Non-Operating Income | $-10.92MM | $11.19MM | $8.33MM |
| Interest Expense | $2.17MM | $9.16MM | $1.29MM |
| R&D Expense | $12.52MM | $9.15MM | $7.66MM |
| Income(Loss) | $-60.61MM | $-9.22MM | $-2.04MM |
| Profit(Loss)* | $-60.61MM | $-9.22MM | $-1.18MM |
| Stockholders Equity | $13.22MM | $13.46MM | $18.20MM |
| Inventory | $1.95MM | $3.15MM | $2.15MM |
| Assets | $63.92MM | $38.91MM | $40.90MM |
| Operating Cash Flow | $-22.61MM | $-43.87MM | $-8.14MM |
| Capital expenditure | $0.30MM | $0.05MM | $0.03MM |
| Investing Cash Flow | $1.44MM | $29.37MM | $-8.61MM |
| Financing Cash Flow | $15.06MM | $20.66MM | $8.95MM |
| Earnings Per Share** | $-0.94 | $-0.12 | $-0.29 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.